Correlation Between Iovance Biotherapeutics and Alvotech Warrant

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Alvotech Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Alvotech Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Alvotech Warrant, you can compare the effects of market volatilities on Iovance Biotherapeutics and Alvotech Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Alvotech Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Alvotech Warrant.

Diversification Opportunities for Iovance Biotherapeutics and Alvotech Warrant

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Iovance and Alvotech is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Alvotech Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech Warrant and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Alvotech Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech Warrant has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Alvotech Warrant go up and down completely randomly.

Pair Corralation between Iovance Biotherapeutics and Alvotech Warrant

Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Alvotech Warrant. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.46 times less risky than Alvotech Warrant. The stock trades about -0.3 of its potential returns per unit of risk. The Alvotech Warrant is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  251.00  in Alvotech Warrant on December 4, 2024 and sell it today you would lose (31.00) from holding Alvotech Warrant or give up 12.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy93.33%
ValuesDaily Returns

Iovance Biotherapeutics  vs.  Alvotech Warrant

 Performance 
       Timeline  
Iovance Biotherapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Alvotech Warrant 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alvotech Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Alvotech Warrant is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Iovance Biotherapeutics and Alvotech Warrant Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Iovance Biotherapeutics and Alvotech Warrant

The main advantage of trading using opposite Iovance Biotherapeutics and Alvotech Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Alvotech Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech Warrant will offset losses from the drop in Alvotech Warrant's long position.
The idea behind Iovance Biotherapeutics and Alvotech Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges